Literature DB >> 15763748

Cannabis use and psychotic disorders: an update.

Wayne Hall1, Louisa Degenhardt, Maree Teesson.   

Abstract

This paper evaluates three hypotheses about the relationship between cannabis use and psychosis in the light of recent evidence from prospective epidemiological studies. These are that: (1) cannabis use causes a psychotic disorder that would not have occurred in the absence of cannabis use; (2) that cannabis use may precipitate schizophrenia or exacerbate its symptoms; and (3) that cannabis use may exacerbate the symptoms of psychosis. There is limited support for the first hypothesis. As a consequence of recent prospective studies, there is now stronger support for the second hypothesis. Four recent prospective studies in three countries have found relationships between the frequency with which cannabis had been used and the risk of receiving a diagnosis of schizophrenia or of reporting psychotic symptoms. These relationships are stronger in people with a history of psychotic symptoms and they have persisted after adjustment for potentially confounding variables. The absence of any change in the incidence of schizophrenia during the three decades in which cannabis use in Australia has increased makes it unlikely that cannabis use can produce psychoses that would not have occurred in its absence. It seems more likely that cannabis use can precipitate schizophrenia in vulnerable individuals. There is also reasonable evidence for the third hypothesis that cannabis use exacerbates psychosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15763748     DOI: 10.1080/09595230412331324554

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  24 in total

1.  Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas.

Authors:  Maria E Secci; Paola Mascia; Claudia Sagheddu; Sarah Beggiato; Miriam Melis; Andrea C Borelli; Maria C Tomasini; Leigh V Panlilio; Charles W Schindler; Gianluigi Tanda; Sergi Ferré; Charles W Bradberry; Luca Ferraro; Marco Pistis; Steven R Goldberg; Robert Schwarcz; Zuzana Justinova
Journal:  Mol Neurobiol       Date:  2018-08-27       Impact factor: 5.590

Review 2.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 3.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

4.  Cannabis withdrawal in chronic cannabis users with schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Fang Liu; Jared A Linthicum; Hailey Turner; Jennifer R Schroeder; Robert P McMahon; David A Gorelick
Journal:  J Psychiatr Res       Date:  2012-11-10       Impact factor: 4.791

Review 5.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 6.  The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders.

Authors:  Nathan A Kimbrel; Eric C Meyer; Bryann B DeBeer; Suzy B Gulliver; Sandra B Morissette
Journal:  Suicide Life Threat Behav       Date:  2017-03-13

7.  Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptoms.

Authors:  Ian R Gizer; David A Gilder; Philip Lau; Ting Wang; Kirk C Wilhelmsen; Cindy L Ehlers
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

8.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

9.  Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study.

Authors:  Cindy L Ehlers; Ian R Gizer; Cassandra Vieten; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

Review 10.  The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?

Authors:  Lynn E DeLisi
Journal:  Curr Opin Psychiatry       Date:  2008-03       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.